130 related articles for article (PubMed ID: 22103332)
61. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas.
Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Stratigos A; Patereli A; Katsambas A
J Cutan Pathol; 2008 Sep; 35(9):799-808. PubMed ID: 18494826
[TBL] [Abstract][Full Text] [Related]
62. Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7,12-dimethylbenz(a)anthracene application and ultraviolet irradiation.
Husain Z; Pathak MA; Flotte T; Wick MM
Cancer Res; 1991 Sep; 51(18):4964-70. PubMed ID: 1909931
[TBL] [Abstract][Full Text] [Related]
63. Melanocytic differentiation is present in a significant proportion of nonpigmented diffuse neurofibromas: a potential diagnostic pitfall.
Pižem J; Nicholson KM; Mraz J; Prieto VG
Am J Surg Pathol; 2013 Aug; 37(8):1182-91. PubMed ID: 23715161
[TBL] [Abstract][Full Text] [Related]
64. The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions.
Lebe B; Pabuççuoğlu U; Ozer E
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):160-4. PubMed ID: 17525627
[TBL] [Abstract][Full Text] [Related]
65. Dermoscopic features of melanocytic nevi in seven different anatomical locations in patients with atypical nevi syndrome.
Gamo R; Malvehy J; Puig S; Fuentes ME; Naz E; Gómez de la Fuente E; Calzado L; Sanchez-Gilo A; Vicente FJ; Lopez-Estebaranz JL
Dermatol Surg; 2013 Jun; 39(6):864-71. PubMed ID: 23464729
[TBL] [Abstract][Full Text] [Related]
66. Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo.
De Francesco V; Stinco G; Laspina S; Parlangeli ME; Mariuzzi L; Patrone P
Eur J Dermatol; 2008; 18(3):292-6. PubMed ID: 18474458
[TBL] [Abstract][Full Text] [Related]
67. Dermoscopy patterns of halo nevi.
Kolm I; Di Stefani A; Hofmann-Wellenhof R; Fink-Puches R; Wolf IH; Richtig E; Smolle J; Kerl H; Soyer HP; Zalaudek I
Arch Dermatol; 2006 Dec; 142(12):1627-32. PubMed ID: 17178990
[TBL] [Abstract][Full Text] [Related]
68. Morphologic changes of acquired melanocytic nevi with eccentric foci of hyperpigmentation ("Bolognia sign") assessed by dermoscopy.
Pizzichetta MA; Massone C; Grandi G; Pelizzo G; Soyer HP
Arch Dermatol; 2006 Apr; 142(4):479-83. PubMed ID: 16618868
[TBL] [Abstract][Full Text] [Related]
69. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study.
Makhlouf HR; Ishak KG; Shekar R; Sesterhenn IA; Young DY; Fanburg-Smith JC
Arch Pathol Lab Med; 2002 Jan; 126(1):49-55. PubMed ID: 11800647
[TBL] [Abstract][Full Text] [Related]
70. Eruptive melanocytic nevi in patients with renal allografts: report of 10 cases with dermoscopic findings.
Alaibac M; Piaserico S; Rossi CR; Foletto M; Zacchello G; Carli P; Belloni-Fortina A
J Am Acad Dermatol; 2003 Dec; 49(6):1020-2. PubMed ID: 14639379
[TBL] [Abstract][Full Text] [Related]
71. Dermoscopic patterns of melanocytic nevi in children and adolescents: a cross-sectional study.
Piazza CD; Yamada S; Marcassi AP; Maciel MG; Seize MP; Cestari SCP
An Bras Dermatol; 2017; 92(3):340-344. PubMed ID: 29186245
[TBL] [Abstract][Full Text] [Related]
72. Dermoscopic features of congenital melanocytic nevus and Becker nevus in an adult male population: an analysis with a 10-fold magnification.
Ingordo V; Iannazzone SS; Cusano F; Naldi L
Dermatology; 2006; 212(4):354-60. PubMed ID: 16707885
[TBL] [Abstract][Full Text] [Related]
73. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions.
Nielsen PS; Riber-Hansen R; Steiniche T
Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457
[TBL] [Abstract][Full Text] [Related]
74. Melanocytic nevus count and dermoscopic features do not differ in psoriatic patients undergoing biological agent versus conventional drug therapy.
Pirmit S; Onsun N; Su O; Ozkaya DB
G Ital Dermatol Venereol; 2017 Apr; 152(2):126-131. PubMed ID: 28166613
[TBL] [Abstract][Full Text] [Related]
75. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
Mehregan DR; Hamzavi I
Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
[TBL] [Abstract][Full Text] [Related]
76. Dermoscopic features of common nevi: a review.
Kim JK; Nelson KC
G Ital Dermatol Venereol; 2012 Apr; 147(2):141-8. PubMed ID: 22481577
[TBL] [Abstract][Full Text] [Related]
77. Can early malignant melanoma be differentiated from atypical melanocytic nevi by in vivo techniques?: Part I. Clinical and dermoscopic characteristics.
Rao BK; Marghoob AA; Stolz W; Kopf AW; Slade J; Wasti Q; Schoenbach SP; De-David M; Bart RS
Skin Res Technol; 1997 Feb; 3(1):8-14. PubMed ID: 27333167
[TBL] [Abstract][Full Text] [Related]
78. Dermoscopy for congenital melanocytic nevi.
Lodha R; McDonald WS; Elgart GW; Thaller S
J Craniofac Surg; 2003 Sep; 14(5):661-5. PubMed ID: 14501325
[TBL] [Abstract][Full Text] [Related]
79. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers.
Zavala-Pompa A; Folpe AL; Jimenez RE; Lim SD; Cohen C; Eble JN; Amin MB
Am J Surg Pathol; 2001 Jan; 25(1):65-70. PubMed ID: 11145253
[TBL] [Abstract][Full Text] [Related]
80. Clinical and dermoscopic (in vivo and ex vivo) predictors of recurrent nevi.
Heck R; Ferrari T; Cartell A; Bakos RM
Eur J Dermatol; 2019 Apr; 29(2):179-184. PubMed ID: 30907363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
